Abstract
Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Adolescent Psychiatry
Title:PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families
Volume: 2 Issue: 3
Author(s): Ana Ruiz-Sancho, Ana Calvo, Marta Rapado-Castro, Miguel Moreno, Carmen Moreno, Teresa Sanchez-Gutierrez, Cecilia Tapia, Guadalupe Chiclana, Pamela Rodriguez, Patricia Fernandez, Celso Arango and Maria Mayoral
Affiliation:
Keywords: Adolescents, family intervention, group therapy, psychoeducational, psychosis, treatment.
Abstract: Interest in the effectiveness of psychological interventions in patients with psychosis has increased in the last 2 decades, and early intervention programs are increasingly common. PIENSA (Programa de Intervención en Psicosis Adolescente; Intervention Program for Adolescent Psychosis) is a clinical program and pilot study based on previous research into the efficacy of early intervention in preventing relapse and improving outcome in patients with first-episode psychosis.
We describe a psychoeducational intervention designed for adolescents with early-onset psychosis and their parents. The intervention is adapted from McFarlane’s Multiple Family Therapy model to our setting and population (adolescents treated in the Spanish public health system). It consists of 2 stages: an individual stage comprising 3 sessions and a subsequent group stage comprising 12 sessions. The total program lasts for 1 academic year (9 months).
We present the design of our program and our preliminary experience in a Child and Adolescent Unit in Spain.
Export Options
About this article
Cite this article as:
Ruiz-Sancho Ana, Calvo Ana, Rapado-Castro Marta, Moreno Miguel, Moreno Carmen, Sanchez-Gutierrez Teresa, Tapia Cecilia, Chiclana Guadalupe, Rodriguez Pamela, Fernandez Patricia, Arango Celso and Mayoral Maria, PIENSA: Development of an Early Intervention Program for Adolescents With Early-Onset Psychosis and Their Families, Adolescent Psychiatry 2012; 2 (3) . https://dx.doi.org/10.2174/2210676611202030229
DOI https://dx.doi.org/10.2174/2210676611202030229 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peptides and their Metal Complexes in Neurodegenerative Diseases: from Structural Studies to Nanomedicine Prospects
Current Medicinal Chemistry Aryl Maleimides as Apoptosis Inducers on L5178-Y Murine Leukemia Cells (in silico, in vitro and ex vivo Study)
Anti-Cancer Agents in Medicinal Chemistry Transcriptional Regulation and Expression of CYP3A4 in Hepatocytes
Current Drug Metabolism <i>Helicobacter pylori</i> Reactivates Human Immunodeficiency Virus-1 in Latently Infected Monocytes with Increased Expression of IL-1β and CXCL8
Current Genomics Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation
Current Alzheimer Research Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review
Current Neuropharmacology New Prospects for Glycopeptide Based Analgesia: Glycoside-Induced Penetration of the Blood-Brain Barrier
Current Drug Delivery Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases
Current Pharmaceutical Design Human Use of Leucoselect® Phytosome® with Special Reference to Inflammatory- Allergic Pathologies in Frail Elderly Patients
Current Pharmaceutical Design Structure Solution of Misfolded Conformations Adopted by Intrinsically Disordered Alzheimers Tau Protein
Protein & Peptide Letters Patent Selections
Recent Patents on Cardiovascular Drug Discovery Pharmacological and Non Pharmacological Strategies in the Management of Coronary Artery Disease and Chronic Kidney Disease
Current Cardiology Reviews Germans Reporting About their Childhood in the WWII and the Nazi Era
Adolescent Psychiatry Assessment of Phytochemicals and Herbal Formula for the Treatment of Depression through Metabolomics
Current Pharmaceutical Design Major Depressive Disorder and Diabetes: Does Serotonin Bridge the Gap?
Current Diabetes Reviews Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Current Topics in Medicinal Chemistry Update on Autoimmune Diseases Pathogenesis
Current Pharmaceutical Design Cannabinoids in Energy Balance and Prospectives in the Therapy of Obesity
Current Medicinal Chemistry - Central Nervous System Agents Valproate and Neuroendocrine Changes in Relation to Women Treated for Epilepsy and Bipolar Disorder: A Review
Current Medicinal Chemistry